Alphamab Oncology

HKEX:9966.HK

3.21 (HKD) • At close January 15, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q4
Operating Activities:
Net Income -44.896-170.731-39.862-178.413-147.309-145.053-267.364-324.666-103.1-773.955-58.785-97.892-51.951-37.461-16.531-8.265
Depreciation & Amortization 37.29236.76532.35331.91423.27421.72419.37816.01214.1156.7445.0294.4882.0741.6410.2570.129
Deferred Income Tax 002.316-18.40819.72810.4092.616-2.605-11.719-64.2040-9.5710000
Stock Based Compensation 1.1149.2464.0468.0745.2184.1034.06512.64120.08678.66712.35622.7560.263000
Change In Working Capital 3.161-3.40913.2044.5541.971-21.203-1.242-30.111-5.072-14.053-42.278-8.095-7.437-0.831-0.326-0.163
Accounts Receivables -6.03516.424-8.065-0.65-7.234-7.60601.293-1.293-9.051-24.128-14.639-2.401000
Change In Inventory 13.584-15.8141.70310.984-17.712-6.906-6.681-11.329-7.074-5.412-13.4381.454-5.036-0.896-1.561-0.78
Change In Accounts Payables 00000000000-1.6620000
Other Working Capital -4.388-4.01919.566-5.7826.917-6.6915.439-20.0753.2950.41-4.7125.0900.0641.2350.617
Other Non Cash Items -42.663-1.074-83.377-20.403-29.18835.86529.127126.805-73.89587.114-26.33634.10830.56813.183-15.981-7.991
Operating Cash Flow -45.992-129.203-73.636-154.274-146.034-104.564-216.036-199.319-147.861-115.483-110.014-67.391-26.483-23.469-32.581-16.29
Investing Activities:
Investments In Property Plant And Equipment -4.865-14.065-22.119-64.76-64.891-100.655-57.464-45.779-45.043-97.739-73.634-46.536-26.582-18.28-4.175-2.088
Acquisitions Net 00000000000125.5020000
Purchases Of Investments 00000000000-287.2770-12.225-17-8.5
Sales Maturities Of Investments 00000000000161.776012.37522.22511.113
Other Investing Activites 42.81152.433-134.356478.127502.2814.92717.463219.568-1,652.429160.362-643.0025.201-4.19318.13-1.05-0.525
Investing Cash Flow 37.945138.368-156.475413.367437.389-85.735659.999173.789-1,697.47262.623-716.636-41.335-30.775-18.131.050.525
Financing Activities:
Debt Repayment 62.5380-61.7190-111.758081.0120-4.375040.529052.987000
Common Stock Issued 00000000000411.54700.00200
Common Stock Repurchased 0000000000000000
Dividends Paid 0000000000000000
Other Financing Activities -4.45-39.557319.348-186.156-12.988288.451-5.561-31.003221.9571,667.683405.369727.98617.827-58.58110.5
Financing Cash Flow 58.088-39.557257.629-186.156-124.746288.45175.451-31.003217.5821,667.683445.898727.98670.814-58.58110.5
Other Information:
Effect Of Forex Changes On Cash 4.165-19.92239.59518.8857.4523.136-2.7171.6610.078-0.6180.302-8.69802.18430.53715.268
Net Change In Cash 1,140.194067.11391.822174.061101.288516.697-54.872-1,627.6731,614.205253.562443.81723.15158.4140.0030.003
Cash At End Of Period 1,140.1941,136.3021,136.3021,069.189977.367803.306702.018185.321240.1931,867.767253.562466.96723.15158.4280.0140.014